Antisense modulation of cell division cycle 2 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsNicholas M. Dean, Susan M. Freier
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of cell division cycle 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding cell division cycle 2. Methods of using these compounds for modulation of cell division cycle 2 expression and for treatment of diseases associated with expression of cell division cycle 2 are provided.
Claims20
A compound 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding cell division cycle 2, wherein said compound specifically hybridizes with said nucleic acid molecule encoding cell division cycle 2 and inhibits the expression of cell division cycle 2.
A compound 8 to 80 nucleobases in length which specifically hybridizes with at least an 8-nucleobase portion of a preferred target region on a nucleic acid molecule encoding cell division cycle 2.
A method of screening for an antisense compound, the method comprising the steps of:
- a. contacting a preferred target region of a nucleic acid molecule encoding cell division cycle 2 with one or more candidate antisense compounds, said candidate antisense compounds comprising at least an 8-nucleobase portion which is complementary to said preferred target region, and
- b. selecting for one or more candidate antisense compounds which inhibit the expression of a nucleic acid molecule encoding cell division cycle 2.
Dependencies are inferred from the claim text.